May
Drug Discovery Biology
&
Bioinformatics
Strategy Meeting East Coast USA 2024
Pushing our understanding of the physiological context and quality of drug target characterisation, validation, and safety profiling throughout the preclinical space
What makes our strategy meetings unique?
Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.
Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.
Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.
Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.
Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Meet Our Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our upcoming strategy meeting.
Douglas Kitchen
Research Fellow, Medicinal Chemistry CuriaGreg Williams
Senior Research Scientist II, Cellular Assay Technologies CuriaSteven Ring
Senior Research Scientist II, Drug Metabolism and PharmacoKinetics CuriaAaron Mackey
Former SVP, AI & Data Science Sonata TherapeuticsAbhijat Vatsyayan
Head of Artificial Intelligence Taiho OncologyAndrew Zhang
Director, Head of Chemical Biology AstraZenecaAngela Huang
Founder and President Tempo BioscienceClaudette Fuller
Vice President, Head of Non-Clinical Safety & Toxicology GenmabErnane Souza, PhD, RPh
Assistant Director, Translational PKPD and DMPK Supernus Pharmaceuticals IncFrank Leu
Founder & Managing Member/ Managing Member BioPharMatrix LLC/ Novapeutics LLCGunaretnam Rajagopal
Venture Partner Samsara BiocapitalMarcie Glicksman
Vice President, Biology EnClear TherapeuticsMark Tornetta
VP of Biologics Discovery Tavotek BiotherapeuticsNikolaos Tezapsidis
CEO Neurotez Inc.Paul Kayne
Vice President, Biological Sciences Palatin TechnologiesSee Which Topics Are Discussed at the Strategy Meeting
Roundtable Tracks
1Maximizing The Potentials Of Multiomics In Target Identification And Safety Profiling
-Paul Kayne
Vice President, Biological Sciences
Palatin Technologies
DMPK / ADME & Toxicology
Advancing Drug Discovery and Safety Assessment with AI/ML: Where We Are And Where We Re Going
-Claudette Fuller
Vice President, Head of Non-Clinical Safety & Toxicology
Genmab
In Vivo and In Vitro Pharmacology
Latest Approaches And Trends For Improving Nonclinical Studies
-Angela Huang
Founder and President
Tempo Bioscience
In Silico Biology / AI & ML / Blockchain and Bioinformatics Data Integration / Data Mining
Harnessing The Promise Of Generative AI To Transform Drug Discovery Hence Forward
-Aaron Mackey
Former SVP, AI & Data Science
Sonata Therapeutics
Strategic Partnerships, Investment & Collaborations
Forming Strategic Partnerships:
Collaboration or M&A?
-Nikolaos Tezapsidis
CEO
Neurotez Inc.
Roundtable Tracks
2Probing ways to access greater target space and expand the druggable genome to a larger therapeutic area to discover new drugs
SPONSOR
DMPK / ADME & ToxicologyIntegrating Breakthroughs In In Silico In Vivo And In Vitro Pharmacology To Enhance ADMET Modeling
SPONSOR
In Vivo and In Vitro PharmacologyIdentifying The Rein Of Using Animal Models In Pre Clinical Testing And Combining Current In Vitro Technique To Achieve Desired Result
SPONSOR
In Silico Biology / AI & ML / Blockchain and Bioinformatics Data Integration / Data MiningLeveraging AI Target Selection Technologies Strategies And Infrastructure Tools To Support Computational Biology
SPONSOR
Strategic Partnerships, Investment & CollaborationsConsidering Contemporary Techniques In Adapting Go-To-Market Approach
SPONSOR
Roundtable Tracks
3Reducing Attrition Rate By Employing Groundbreaking Technologies At Discovery Stage And Accelerate The Process
-Mark Tornetta
VP of Biologics Discovery
Tavotek Biotherapeutics
DMPK / ADME & Toxicology
Exploring The Use Of Organ-On-Achip And Other Microphysiological Systems For High Throughput Toxicity Screening ADME Studies And Prediction Of Drug Safety Profiles
In Vivo and In Vitro Pharmacology
What Are The Latest Wins In Determining Unresolved Pathophysiology Of Some Diseases Like Alzheimers And What Does It Says About The Future Of Drug Discovery? (Topic TBC)
-Marcie Glicksman
Vice President, Biology
EnClear Therapeutics
In Silico Biology / AI & ML / Blockchain and Bioinformatics Data Integration / Data Mining
Current Adoption And Best Use Of Disruptive Techs (Blockchain, AI And Ml) In Drug Discovery And Development
-Frank Leu
Founder & Managing Member/ Managing Member
BioPharMatrix LLC/ Novapeutics LLC
Strategic Partnerships, Investment & Collaborations
Challenges of Developing ADCs and Immunomodulatory Bispecific Biologics
-Rakesh Dixit, Ph.D
President & CSO
Regio Biosciences
Roundtable Tracks
4Navigating Target Selection and Validation in Drug Discovery: Criteria, Strategies and Models
-Marcie Glicksman
Vice President, Biology
EnClear Therapeutics
DMPK / ADME & Toxicology
Advances In Computational Models And Machine Learning Techniques For A More Precise Prediction Of ADME Properties And Process
In Vivo and In Vitro Pharmacology
Evaluating Engineered Organ-On-Chip Technology In Combination With Other Techniques To Address The Problem Of Heterogenous Diseased Population
In Silico Biology / AI & ML / Blockchain and Bioinformatics Data Integration / Data Mining
Decoding Omics Data Interpretation Integration And Application In Drug Discovery Through The Lense Of In Silico Biology (Topic TBC)
-Abhijat Vatsyayan
Head of Artificial Intelligence
Taiho Oncology
Strategic Partnerships, Investment & Collaborations
What Are Some Of The Effective Ways To Initiate Financial Strategies Using The Go-to- Fundraising Model
Tackling the pros and cons of different financing blueprint: go-to-clinic vs go-to-market vs go-to-fundraising strategies and the criteria to determine which program an organization can adapt
Reasons To Attend Our Strategy Meetings
Fully Interactive Format
There’s only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter
Senior Decision Makers
All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard
Personalised Agendas
Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we’ll create a personalised agenda just for you
Private and Intimate Networking
Small group discussions, private meetings, networking drinks – however you choose to make those important connections our Strategy Meetings have the solution
Testimonials
Hotel & Venue
Hyatt Regency Princeton
Hyatt Regency Princeton hotel is conveniently located near corporate offices and attractions, as well as the Mercer County Airport.
Hotel Details Map & Directions ParkingHere To Help
Need help registering your team? Just get in touch and a member of the team will be happy to help.